Amanda C Przespolewski (Amanda Przespolewski)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Peritoneal Dialysis

Prognostic Factors

Ejection Fraction

Top Venues

Leukemia & lymphoma

This page only lists publications with an associated author ORCID identifier.

Publications

Amanda C Przespolewski, Aaron D Goldberg, Chetasi Talati, Salman Fazal, Pankit Vachhani, Srinivasa Reddy Sanikommu, Swapna Thota, Julian A Waksal, Brian John Ball, Christopher A Famulare, Maximilian Stahl, Jeffrey Baron, Elizabeth A Griffiths, James E Thompson, Kendra L Sweet, Eunice S Wang
Safety and efficacy of CPX-351 in younger patients (< 60 years) with secondary acute myeloid leukemia. Blood (2022)
Amanda C Przespolewski, Aaron D Goldberg, Chetasi Talati, Salman Fazal, Pankit Vachhani, Srinivasa Reddy Sanikommu, Swapna Thota, Julian A Waksal, Brian John Ball, Christopher A Famulare, Maximilian Stahl, Jeffrey Baron, Elizabeth A Griffiths, James E Thompson, Kendra L Sweet, Eunice S Wang
Safety and efficacy of CPX-351 in younger patients (< 60 years) with secondary acute myeloid leukemia. Blood (2022)
Amanda C Przespolewski, Monica R Muppidi, Craig W Freyer, Wenyan Ji, Tara L Cronin, Swapna Thota, Elizabeth A Griffiths, James E Thompson, Evelena P Ontiveros, Jeffrey Baron, Amro Elshoury, Eunice S Wang
Cladribine, cytarabine, and GCSF with and without mitoxantrone (CLAG ± M) is highly effective for poor risk acute myeloid leukemia with adverse karyotype and prior hypomethylating therapy. Leukemia & lymphoma 62 (7) (2021)
Amanda C Przespolewski, Scott Portwood, Eunice S Wang
Targeting acute myeloid leukemia through multimodal immunotherapeutic approaches. Leukemia & lymphoma (2021)
Craig W Freyer, Chelsea E Peterson, Yun Man, Amanda C Przespolewski, Jeffrey Baron, Selina M Luger
Herpes zoster during arsenic trioxide therapy for acute promyelocytic leukemia. Leukemia & lymphoma 62 (3) (2020)